#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Chondrosarcoma metastatic Brain abscess Thyroid cancer metastatic Neuroendocrine carcinoma of the skin Graft versus host disease Glioma Exudative retinopathy Partial lipodystrophy Epilepsy with myoclonic-atonic seizures Peritoneal mesothelioma malignant Mantle cell lymphoma stage III Porphyria non-acute Rheumatoid arthritis Anaplastic large cell lymphoma T- and null-cell types Alveolar rhabdomyosarcoma More trials…

    Learn about Rare Diseases

    Aicardi-Goutieres syndrome – Basic Information Hepatoblastoma – Trials in Disease Friedreich’s ataxia – Trials in Disease Mantle cell lymphoma – Diagnostics Burkitt’s lymphoma – Trials in Disease Chordoma – Life with Disease Loeys-Dietz syndrome – Diagnostics Paroxysmal nocturnal haemoglobinuria – Treatment Sarcoma – Life with Disease Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Gen1055 Azd0305 Gabapentin Fosaprepitant Tianeptine Tasipimidine DNL593 ARTICAINE HYDROCHLORIDE Promethazine Hydrochloride Magnesium Citrate SODIUM DIHYDROGEN PHOSPHATE Lidocaine Garetosmab Glimepiride Norucholic Acid Lamotrigine Denosumab ABBV-CLS-628 Glpg3667 Fumarate Amylase More therapies…

    Learn about Your Condition

    Cholangitis sclerosing Medication overuse headache Neuromuscular scoliosis Injection site pain Gastrectomy Bronchostenosis Proteus syndrome Triple positive breast cancer Pulmonary hypertension Osteomyelitis Lupus nephritis Open angle glaucoma Acromegaly Subarachnoid haemorrhage Anal fissure More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Factor VIII deficiency

  • Evaluation of NXT007 versus Emicizumab Prophylaxis in Patients with Hemophilia A

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Factor VIII deficiency
    Investigated Drugs:
    • Emicizumab
    • Ro7589655
    Austria Belgium Denmark France Germany Hungary +5

  • A Phase III study of NXT007 compared with simoctocog alfa prophylaxis in patients with Hemophilia A without inhibitors

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Factor VIII deficiency
    Investigated Drugs:
    • Ro7589655
    • Simoctocog Alfa
    Austria Denmark France Germany Hungary Italy +3

  • A study on the long-term safety and effectiveness of giroctocogene fitelparvovec or fidanacogene elaparvovec in patients with hemophilia A or hemophilia B

    Recruiting

    3 1 1
    Investigated Diseases:
    • Factor IX deficiency
    • Factor VIII deficiency
    Investigated Drugs:
    • Fidanacogene Elaparvovec
    • Giroctocogene Fitelparvovec
    France Germany Greece Italy Spain Sweden

  • A study of long-term safety and effectiveness of denecimig in people with haemophilia A with or without inhibitors

    Recruiting

    3 1 1
    Investigated Diseases:
    • Haemophilia A with anti factor VIII
    • Factor VIII deficiency
    Austria Belgium Bulgaria Denmark France Germany +10

  • Study on Long-Term Effects of Efanesoctocog Alfa in Preventing Joint Bleeds in Patients with Hemophilia A

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Factor VIII deficiency
    Investigated Drugs:
    • Efanesoctocog Alfa
    Croatia Czechia France Germany Ireland Italy +2

  • Study on Emicizumab and Drug Combination for Patients with Haemophilia A and FVIII Inhibitors

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Factor VIII deficiency
    Investigated Drugs:
    • Eptacog Beta (Activated)
    • Factor Viii Inhibitor Bypassing Fraction
    • Human Coagulation Factor Viii
    Bulgaria Croatia Finland Germany Norway Spain +1
1 2 3 … 5
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!